Neudle.com: neuromuscular blocking agents

Differential
(Click to cross reference)

abdominal distention

abducens nerve paralysis

abducens nerve paralysis, bilateral

abiotrophy

abortion, spontaneous

abscess, intracerebral

accomodation, abnormal

acetylcholine receptor

acetylcholine receptor antibody

acoustic nerve

acoustic neurinoma, bilateral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome myelopathy

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

acrylamide

ACTH

acute intermittant porphyria

acyclovir

adalimumab

addiction, heroin

addiction, heroin-neurologic complications with

adrenergic blocker

adrenoleukodystrophy

advances in neurology

adverse drug reaction

alcohol block, subarachnoid

alcohol intolerance

alcohol, heart involvement with

alcohol, neurologic complications with

altered states of consciousness

alternating hemiplegia

alternating rapid movement, impaired

aluminum

alveolar hypoventilation

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, guamian type of

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, myasthenic syndrome with

amyotrophic lateral sclerosis, Parkinson-dementia-complex

amyotrophic lateral sclerosis, prognosis

amyotrophic lateral sclerosis, treatment of

amyotrophic lateral sclerosis-like syndrome

ANA

anal wink response

anemia

anemia, megaloblastic

anencephaly

anesthesia, general

anesthesia, local

aneurysm, intracranial

angiography, cerebral, beaded vessels

angiography, cerebral

angiotensin-converting enzyme

anterior horn cell disease

anterior tibial muscle weakness

anti citrullinated antibody

antibiotics, neurologic complications with

antibodies to voltage-gated calcium channels

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, untoward effects of

antifungal agent

antimetabolite

antineutrophil cytoplasmic autoantibodies

antistriational muscle antibody

antithymocyte antiserum

apraxia of eye movements

arthropathy, neuropathic

ascending paralysis

asparginase

aspartate aminotransferase

ataxia telangiectasia

atrioventricular block

atropine

attention deficit disorder with hyperactivity

atypical

audiogram

auditory evoked brainstem potentials

auditory evoked potentials

autoantibodies

autoimmune disease

autonomic dysfunction

autonomic dysfunction, acute

B cell lymphocyte depletion

Babinski sign

BAL

barium poisoning

Barkhof MR criteria for MS

basal ganglia

basal ganglia, lesion of

basophilic stippling of red blood cells

Bassen-Kornzweig syndrome

behavioral disorder

Bell's phenomenon

beta adrenergic blocker

bezafibrate

Bielschowsky head tilt test

blood dyscrasias, neurologic findings with

bone marrow suppression

bone marrow transplantation

botulinum toxin

botulinum toxin, complications of

botulism

botulism antitoxin

botulism immune globulin

botulism, infant

botulism, relapse

brachial neuritis

brachial neuritis, acute

brachial plexus injury

brachial plexus neuropathy

brain atrophy

brain biopsy

brain biopsy, stereotaxic

brain fog

brain natriuretic peptide

brain scan, abnormal

brainstem, dysfunction

brainstem, infarction of

breast feeding

bulbar palsy

bulbar palsy, acute

bulbar palsy, progressive

burning feet

burning feet, differential diagnosis of

burning paresthesia

cafe au lait spots

calcium antagonist

calcium antagonist, side effects of

calcium channel dysfunction

caloric testing

cancer associated myopathy

carcinoembryonic antigen

cardiac surgery, neurologic complications with

cardiac transplantation

cardiomegaly

cardiomyopathy

cardiotoxicity

cardiovascular disease

carpal tunnel syndrome

CAT scan, complication with

CAT scan, contrast enhanced

cauda equina, enhancement

cauda equina, lesion of

CD4 counts

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, children

cerebellar ataxia, hereditary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebellum, disease of

cerebral cortical atrophy

cerebral death

cerebral edema

cerebral infarction

cerebral infarction, small, deep

cerebral ischemia

cerebro hepato renal syndrome

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cytology

cerebrospinal fluid, cytology, false negative

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, pressure increased

cerebrospinal fluid, pressure low

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, mimics

cerebrovascular accident, postoperative

chemotherapy, CNS treatment and complications with

chemotherapy, intra-arterial

chest pain

chest x-ray, abnormal

children

chills

Chinese paralytic syndrome

chromosomal abnormality

chromosome 11

chromosome 12

chronic fatigue syndrome

chronic graft versus host disease

chronic progressive external ophthalmoplegia

Churg-Strauss syndrome

Clinical Pathologic Conference(C.P.C.)

collagen vascular disease

compression neuropathy

concentration, impaired

conduction block

confusion

congenital birth defects

congenital malformation

congenital myopathy

congestive heart failure

constipation

contactin associated protein like 2 antibodies

contractures, joint

contraindications

contrast agents, neurotoxicity of

controversies in neurology

conversion reaction

Coombs test, positive

corpus callosum, lesion of

cost effectiveness

cough

cranial nerve enhancement

cranial nerve palsies

cranial nerves, toxins effecting

cranial neuropathy

cranial neuropathy, multiple

creatine kinase

creatine phosphokinase(CPK)elevated

cryptococcal meningitis

Cuba

cyclophosphamide

cyclosporine

cystometrogram, abnormal

cytoid bodies

cytokines

cytomegalic inclusion disease

cytomegalovirus infection

degenerative diseases of CNS

delay in diagnosis

delirium

dementia

demyelinating disease

dental procedure, neurologic complications with

dermatitis

dermatomyositis

descending paralysis

developmental disability

developmental evaluation

diaphragmatic paralysis

differential diagnosis

difficulty going down stairs

diffuse infiltrative lymphocytosis syndrome

dilantin

dilantin, toxicity

dimethylamine borane

dimethylaminopropronitrile

disability rating scale, neurological

disability, neurological

distal muscle weakness

dropped head syndrome

drowsiness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug addiction

drug induced neurologic disorders

dysequilibrium syndrome

dystrophic calcification

ejaculation, retrograde

ejection fraction, abnormal

electrical sensation

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

electromyogram, decremental response

electromyogram, incremental response

electron microscopy

electronystagmography

electroretinograph

ELISA

embryonic sensory peripheral neuropathy

emergencies, medical

emergencies, neurologic

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, recurrent

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, anoxic

encephalopathy, metabolic

encephalopathy, post anoxic

encephalopathy, septic

endocarditis, marantic

enzyme, muscle disease

enzyme, serum

eosinophilia

eosinophilia-myalgia syndrome

epidemic

epidemiology of neurology

epilepsia partialis continua

epsilon-aminocaproic acid(E.A.C.A.)

evidence-based research

evoked potentials

excitotoxin

exercise

exercise-related muscle strength increase

exome sequencing

eye closure

eye movement, disorders of

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

facial weakness

facial weakness, bilateral

fibrinolytic agents, complications

fine motor function, impaired

fingernails, abnormal

frontal lobe, pathologic signs of

frozen section

fundus, abnormality of

fungal infection, CNS

F-wave response

gadolinium

gag reflex, depressed

gait disorder

gallium scan

gammaglobulin therapy, intravenous

gastrointestinal bleeding

gastroparesis

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

GM1 ganglioside antibodies

gout

gram positive rod

granuloma, eosinophilic

granulomatosis with polyangiitis

granulomatous disease

grasp reflex

Graves ophthalmopathy

growth retardation

guanidine

Guillain Barre syndrome

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, infantile and childhood form

Gulf War syndrome

Hallervorden Spatz disease

hallucination

hallucination, visual

hearing loss, bilateral

heart block

heart wall motion dysfunction

heat intolerance

heavy metal intoxication

hemiballismus

hemiparesis

hemiparesis, transient

hemiplegia

hemoglobinuria

hemophagocytic lymphohistiocytosis, cerebromeningeal

heralding manifestation

herbs

herpes labialis

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes simplex virus, human nervous system and

herpes virus

herpes virus infection

herpes zoster

high arched feet

highly active antiretroviral therapy

hip arthroplasty

hip flexor weakness

hippocampus

histamine-2 receptor blockers

HLA

HMGcoA reductase inhibitors

hoarseness

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

human diploid cell rabies vaccine

human herpesvirus 6

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

human immunodeficiency virus type 1, pathogenesis

human T-lymphotropic virus type I(HTLV-I)

hypertrophic intracranial pachymeningitis

hypocalcemia

hypocomplementemia

hypofibrinogenemia

hypogammaglobulinemia

hypothalamus, lesion of

hypothyroidism

hypotonia

hypotonia, infants

hypoxic encephalopathy

iatrogenic neurologic disorders

idiopathic inflammatory myopathy

ileus, paralytic

illusions

imbalance

immune checkpoint inhibitors

immune-related adverse events

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

impotence

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inclusion bodies

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion body myositis

industrial neurologic disorders

inebilizumab

infant, evaluation of

internuclear ophthalmoplegia

interstitial pulmonary fibrosis

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial pressure, increased

intrathecal chemotherapy

intravenous drug abuse

intrinsic hand muscles, wasting of

Kearns-Sayre syndrome

keratoconjunctivitis

Korsakoff's psychosis

Laurence-Moon-Bardet-Biedl syndrome

lead and the nervous system

lead poisoning

leg weakness, bilateral

leg weakness, unilateral

leprosy

lethargy

leukemia

leukemia, neurologic findings assoc.with

leukocytosis

leukodystrophy

leukopenia

level of consciousness, decreased

levonorgestrel

Lhermitte's sign

lid abnormalities

lid closure, weakness of

lid twitch

life expectancy

life support, withdrawal of

life sustaining treatment

lipoprotein receptor-related protein 4

liquorice

listeria monocytogenes

listeriosis, CNS

lithium

liver disease

liver function enzymes

liver transplantation

lumbosacral plexopathy

lumbosacral plexus

lumbosacral plexus, lesion of

lumbosacral plexus, neuritis

Lyme disease

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, meningeal

lymphoma, primary of CNS

lysosomal storage disease

Mary Walker phenomenon

mediastinum, mass of

medical-legal aspects of neurology

Mees lines

MEK inhibitor

melanoma, malignant

memory, defect of recent

memory, impairment of

Meniere's disease

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neurologic aspects and complications of

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental retardation

mental status, abnormal

methylhydrazine derivatives

methylmalonic acid, serum

methylmalonic acidemia

methyl-n-butyl ketone

metronidazole

microabscesses, cerebral

microscopic polyangiitis

midbrain, infarction of

mitochondrial disease

mitochondrial encephalomyopathy

mitral valve vegetation

molecular genetics

monoamine oxidase inhibitors

monoclonal antibodies

monoclonal gammopathy

monoclonal gammopathy of uncertain significance

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

mortality

Morvan's fibrillary chorea

mosquito

motor neuron disease

movement disorder

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, high signal foci on

MRI, spinal cord, increased intramedullary cord signal

MRI, sulcal hyperintensity

mucopolysaccharidoses

multinucleated giant cell

multiple organ failure

multiple sclerosis

multiple sclerosis, misdiagnosis

multiple sclerosis, treatment of

multiple system atrophy

muscle atrophy, progressive

muscle atrophy, static

muscle strength, testing

muscle swelling

muscle tenderness

muscle twitching

muscle wasting, diffuse

muscle weakness

muscle weakness, insidious onset of

muscle weakness, proximal

muscle weakness, sudden onset of

muscular dystrophy

muscular dystrophy, Becker

muscular dystrophy, Duchenne

muscular dystrophy, facioscapulohumeral

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, cold test for

myasthenia gravis, diagnosis

myasthenia gravis, differential diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, etiology of

myasthenia gravis, exacerbation

myasthenia gravis, infantile and juvenile

myasthenia gravis, misdiagnosis of

myasthenia gravis, neonatal

myasthenia gravis, neuromuscular junction in

myasthenia gravis, ocular

myasthenia gravis, passive transfer of

myasthenia gravis, presenting manifestations

myasthenia gravis, prognosis of

myasthenia gravis, receptor site in

myasthenia gravis, remission of

myasthenia gravis, sensory loss with

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, unmasked

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

mycophenolate

myelitis

myelitis, longitudinal

myelopathy, chronic progressive

myelopathy, tract-specific

myopathy, critically ill

myopathy, drug-induced

myopathy, glycogen storage

myopathy, hypokalemic

myopathy, inflammatory

myopathy, mitochondrial

myopathy, necrotizing

myopathy, necrotizing, autoimmune

myopathy, necrotizing, immune-mediated

myopathy, proximal

myopathy, scleromyxedema

myopathy, steroid induced

necrotizing vasculitis

nemaline rod myopathy

nemaline rod myopathy, adult onset

neoplasm, metastatic

neoplasm, metastatic to lumbosacral plexus

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-intraventricular

neoplasm, second primary

nephritis

nerve agents

nerve biopsy

nerve conduction studies

nerve conduction studies, motor

nerve conduction studies, sensory

neural crest, abnormal

neuralgia

neuritis

neuritis, heavy metals causing

neurocutaneous disease

neuroendocrinology

neurofibromatosis 2

neuroleptic

neurologic complications

neurologic complications of, chronic pulmonary disease

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic evaluation

neurologic examination

neurologic history

neurologic signs

neurologic symptoms

neurological intensive care

neuromuscular blockade

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyotonia

neuronal ceroid-lipofuscinosis

neuronopathy

neuronopathy, sensory

neuroophthalmology

neurootology

neuropathology

neuropathology, peripheral nerves

neuropathy

neuropathy, acute

neuropathy, classification of

neuropathy, cryoglobulinemic

neuropathy, demyelinating

neuropathy, diabetic

neuropathy, diphtheritic

neuropathy, etiologies of

neuropathy, hereditary peripheral

neuropathy, iatrogenic

neuropathy, immune

neuropathy, ischemic

neuropathy, medication induced

neuropathy, motor

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, recurrent

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, nonsystemic

neuropathy, vasculitic, systemic

neuropathy, work up for

neuroprotective agents

numbness, generalized

nutritional deficiency

nystagmus

occupational neurologic disorders

occupational neuropathies

ocular motility, disorders of

oculovestibular reflex

old age, neurology of

ophthalmoplegia

ophthalmoplegia, acute

ophthalmoplegia, bilateral, acute

ophthalmoplegia, total

opisthotonus

opportunistic infection

opportunistic infection, CNS

opsoclonus

opsoclonus-myoclonus syndrome

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, bilateral

optic neuropathy, nutritional

optic neuropathy, toxic

oral contraceptives

orbicularis oculi muscle

organ transplantation

orgasm

orthostatic hypotension

osmotic demyelination syndrome

paralysis, acute areflexic

paresthesias, generalized

paresthesias, hands

Parkinson disease

Parkinson disease, unilateral

Parkinsonism-dementia complex

parotid gland swelling

pathognomonic

pathology

patient information and support

peripheral blood smear

peripheral blood smear, abnormal

peripheral nerve, lesion of

peroneal nerve palsy

peroneal nerve, lesion of

photosensitivity, skin

pigmentary retinopathy

pituitary

pituitary, metastasis to

placebo

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pleural effusion

pleurisy

pneumonia

podophyllin resin toxicity

POEMS syndrome

poison, neurologic problems with

poison, organophosphate

polyclonal gammopathy

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuritis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, chronic relapsing

polyneuropathy, critically ill

polyneuropathy, lymphomatous

polyneuropathy, uremic

polyradiculoneuropathy

porphyria

position sensation, abnormal

positive sharp waves

post herpetic neuralgia

posterior column disease

posterior leukoencephalopathy syndrome

postoperative neurologic complications

potassium channel antibodies

practice guidelines

pravastatin

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

progressive multifocal leucoencephalopathy

progressive neurologic disorder

propranolol

proprioception, abnormal

prostigmine

protease inhibitor, HIV-1

proteinuria

proton pump inhibitors

proximal muscle atrophy

pseudointernuclear ophthalmoplegia

pseudomyasthenia

psychiatric problems in neurologic disorders

psychological testing

psychomotor retardation

pulmonary infiltrates

pupil, abnormality in neurologic disorders

pupil, dilated and fixed, bilateral

pupil, light reflex, abnormal

pyridoxine deficiency

radial nerve, palsy of

radiation hypersensitivity

radiation therapy, CNS treatment and complications with

radiculopathy

radionuclide imaging, heart

radiosensitizing drug

ragged-red fibers

rapidly progressing neurologic illness

rehabilitation for neurologic disorders

remission

remote effect of cancer on the nervous system

renal failure

renal failure, acute

renal transplantation

repetitive nerve stimulation

respirator

respiratory arrest

respiratory depression

respiratory failure

respiratory paralysis, pharmacologic

respiratory tract infection

restless leg syndrome

reticulum cell sarcoma

reverse straight leg raising test

reversible neurologic disorder

review article

rhabdomyolysis

rheumatoid arthritis

rheumatoid arthritis factor(R.A.factor)

rheumatoid arthritis, neurologic complications of

rippling muscle disease

risk factors

risk-benefit assessment

saccadic eye movements

saccadic eye movements, abnormal

safety

salivary gland enlargement

salivation, excessive

scleroderma, neurologic involvement with

sedimentation rate, elevated

segmental demyelination

seizure

selective serotonin reuptake inhibitors

selumetinib

sensorineural hearing loss

sensory ganglia

sensory ganglia, abnormal

sensory loss

sensory loss, asymmetric

sensory polyneuropathy

sensory symptoms

sensory testing

sensory testing, quantitative

septicemia

serologic testing

serologic testing, false negative

seronegative

serum alanine aminotransferase

serum glutamic oxaloacetic transaminase

sex reassignment surgery

sexual dysfunction in neurologic disease

single-fiber electromyography

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, biopsy

skin, discoloration

skin, lesions in neurologic disorders

sleep

sleep apnea

sleep pathology and physiology

slurred speech

small vessel disease

small vessel vasculitis

snake bite

snout reflex

sodium channel dysfunction

solvent

somatosensory evoked potentials

sore throat

speech disorder

spinal cord

spinal cord, compression of

spinal cord, injury of

spinal cord, injury, functional capacity of patient with

spinal cord, injury, sexual dysfunction in

spinal cord, lesion of

spinal muscular atrophy

spinocerebellar degeneration

splenomegaly

squamous cell carcinoma of head and neck

standing difficulty

statin therapy

statin therapy, discontinuation

statin therapy, dose

status asthmaticus

stem cell transplantation

steroid

steroid psychosis

steroid sparing therapy

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage, prognosis

superior oblique myokymia

superior oblique palsy

suramin

sweating

sweating, abnormality of

sympathectomy

sympatholytic agent

symptomatic

syphilis, neurologic complications with

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tapetoretinal degeneration

temporal lobe, lesion

temporal lobe, lesion, bilateral

tensilon

tensilon test

tensilon test, false negative

tensilon test, false positive

tensilon test, paradoxical

tetanus antitoxin

tetany

tetrodotoxin

thalamus, infarction, bilateral

thymus and neuromuscular function

tongue, discoloration

tongue, fasciculations of

tongue, impaired movements of

tongue, pain

tongue, weakness

toxic encephalopathy

toxins, nervous system

toxoplasmosis, acquired

toxoplasmosis, CNS

tracheostomy

trametinib

transcutaneous electrical nerve stimulation

transgender

transient ischemic attack

treatment of neurologic disorder

tremor

tremor, intention

tremor, jaw

tricyclic antidepressant

triorthocresyl phosphate

triphenyltin intoxication

tripping

trochlear nerve palsy

Trousseau's sign

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

uremic encephalopathy

urine test in toxic screen

urine, dark

Usher's syndrome

uveitis

vaccination, neurologic complications with

vacor

valacyclovir

vanadium

varicella zoster virus

vasculitides

vasculopathy

vecuronium

ventricular assist device

vibratory sensation, abnormal

vinblastine

vincristine neurotoxicity

visual acuity, decreased

visual evoked response

Waldenstrom's macroglobulinemia

walking, delayed

walking, difficulty with

weakness, generalized

weakness, infant

weakness, progressive

weakness, proximal

weaning from respirator, failure to

weight loss

Wernicke's encephalopathy

Showing articles 1550 to 1600 of 5819 << Previous Next >>

MRI Findings Associated With Acute Liver Failure
Neurol 72:2130-2131, Fridman,V.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009

Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
Stroke 40:3161-3162, 3163, Strauss,M. &Hall,A., 2009

Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
Stroke 40:3159-3160, 3163, Hackam,D., 2009

Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009

Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Arch Neurol 66:735-741, McKeon,A.,et al, 2009

Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection
Stroke 40:37772-3776, Engelter,S.,et al, 2009

Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Arch Neurol 66:1334-1338, 1322, Suzuki,S.,et al, 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Assessment of Potential Drug Interactions in Patients with Epilepsy: Impact of Age and Sex
Neurol 72:419-425, Gidal,B.E.,et al, 2009

Expansion of the Time Window for Treatment of Acute Ischemic Stroke with Intravenous Tissue Plasminogen Activator: A Science Advisory from the American Heart Association/American Stroke Association
Stroke 40:2945-2948, del Zoppo,G.J.,et al, 2009

MR Mismatch Is Useful for Patient Selection for Thrombolysis: Yes
Stroke 40:2906-2907,2910, Fiebach,J.B. &Schellinger,P.D., 2009

Evaluation and Treatment of Inflammatory Myopathies
JNNP 80:1060-1068, Amato,A. &Barohn,R.J., 2009

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinsons Disease
NEJM 361:1268-1278, 1304, Olanow,C.,et al, 2009

Diagnosis and Therapy in Neuromuscular Disorders: Diagnosis and New Treatments in Mitochondrial Diseases
JNNP 80:943-953, Rahman,S. &Hanna,M.G., 2009

Treatment of Neuromyelitis Optica with Mycophenolate Mofetil
Arch Neurol 66:1128-1133, Jacob,A.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
NEJM 361:1067-1074, Chen,Y.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Brainstem Lesions in Diffusion Sequences of MRI Can be Reversible After Arterial Recanalization
Neurol 73:813-815, Vilas,D., 2009

Combined Corticosteroid and Antiviral Treatment for Bell Palsy: A Systematic Review and Meta-analysis
JAMA 302:985-993, 1003, Almeida,J.,et al, 2009

A Large-Scale International Meta-Analysis of Paraoxonase Gene Polymorphisms in Sporadic ALS
Neurol 73:16-24,11, Wills,A.-M.,et al, 2009

Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients
Stroke 40:2611-2612,2615, Moonis,M., 2009

Is Intraarterial tPA Within 3 Hours the Treatment of Choice for Selected Stroke Patients? No
Stroke 40:2613-2614,2615, Lindley,R.I., 2009

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial
Stroke 40:2433-2437,2295, Saver,J.L.,et al, 2009

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke: A Metaanalysis
Stroke 40:2438-2441, Lansberg,M.G.,et al, 2009

Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
Stroke 40:2594-2600, Saver,J.L.,et al, 2009

A 70-Year-Old Woman with Shingles: Review of Herpes Zoster
JAMA 302:73-80,108, Whitley,R.J., 2009

Diagnosis and New Treatments in Muscular Dystrophies
JNNP 80:706-714, Manzur,A.Y. &Muntoni,F., 2009

A 49-Year-Old Man with Contractures, Weakness, and Cardiac Arrhythmia
Neurol 72:2036-2043, Kissel,J.T.,et al, 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Primary Angiitis of the Central Nervous System
Arch Neurol 66:704-709, Birnbaum,J. &Hellmann,D.B., 2009

Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009

Clinical Spectrum of Ataxia-Telangiectasia in Adulthood
Neurol 73:430-437, Verhagen,M.M.M.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Ann Neurol 66:28-38, Molina,C.A.,et al, 2009

Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Stroke 40:3526-3531,3413, Goldstein,L.,et al, 2009

Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
Stroke 40:e622-e623, Manktelow,B. &Potter,J., 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Cerebral Infarction in POEMS Syndrome: Incidence, Risk Factors, and Imaging Characteristics
Neurol 73:1308-1312, Dupont,S.A.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Showing articles 1550 to 1600 of 5819 << Previous Next >>